The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...

Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...

A Day 3 presentation dives into the impact of copay accumulators, maximizers, and AFPs on driving cost savings.

But a BBC investigation has highlighted that some drug treatments for restless leg syndrome and Parkinson’s disease can lead ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, announced that Randall Moreadith, M ...

Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that ...

After expansions for diagnoses in past legislative sessions, medicinal cannabis are pushing for a legislative change that ...